Tandem Diabetes Care (TNDM) Treasury Shares (2020 - 2024)
Tandem Diabetes Care (TNDM) posted Treasury Shares of $151660.0 for Q4 2024, down 95.23% on a QoQ basis from $3.2 million in Q4 2023, and down 95.23% year-over-year from $3.2 million in Q1 2024.
Tandem Diabetes Care (TNDM) Treasury Shares (2020 - 2024) Analysis & Trends
Tandem Diabetes Care's Treasury Shares history runs 5 years deep, the most recent figure standing at $151660.0 for Q4 2024.
- Quarterly Treasury Shares fell 95.23% year-over-year to $151660.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $151660.0 (down 95.23% YoY) and the FY2024 annual result came in at $151660.0, down 95.23% from the prior year.
- Treasury Shares was $151660.0 for Q4 2024 at Tandem Diabetes Care, down from $3.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $3.2 million in Q4 2023 and bottomed at $132802.0 in Q4 2020.
- A 5-year average of $1.2 million and a median of $610731.0 in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares jumped 359.88% — and 2024, when it tumbled 95.23%.
- Tandem Diabetes Care's Treasury Shares stood at $132802.0 in 2020, then soared by 359.88% to $610731.0 in 2021, then jumped by 200.27% to $1.8 million in 2022, then jumped by 73.2% to $3.2 million in 2023, then tumbled by 95.23% to $151660.0 in 2024.
- Business Quant data shows TNDM's Treasury Shares at $151660.0 in Q4 2024, $3.2 million in Q4 2023, and $1.8 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | 16.94 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 7.70 Mn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 263.29 Mn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 83.00 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | 4.51 Mn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 26.40 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 515.00 Mn |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 14.05 Mn |
| 10 | Tandem Diabetes Care | 1.14 Bn | 574.71 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 151,660.00 |
| Dec 31, 2024 | 151,660.00 |
| Dec 31, 2023 | 3.18 Mn |
| Dec 31, 2023 | 3.18 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 610,731.00 |
| Dec 31, 2021 | 610,731.00 |
| Dec 31, 2020 | 132,802.00 |
| Dec 31, 2020 | 132,802.00 |